![AI概念股大幅走高 OpenAI限制API使用 國內大模型廠商上線「搬家」方案](https://i-invdn-com.investing.com/news/LYNXMPEA7B05U_S.jpg)
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Inventiva SA是一家從事生物技術業務的法國公司。該公司專注於腫瘤、纖維化和罕見疾病領域療法的開發業務。該公司的產品線包括許多開發計劃,如臨床管線、臨床前管線、艾伯維協作和勃林格殷格翰公司協作。它的候選藥物針對非酒精性脂肪性肝炎(NASH)、系統性硬化症(SSc)、各種粘多醣貯積症(MPS)、多發性骨髓瘤、自身免疫性疾病以及肺癌等疾病。此外,該公司在眾多領域提供從靶標識別到臨床前提名的藥物發現服務,如計算機模擬、生物學、篩選、吸收、分佈、代謝和排泄(ADME)、藥理和組織學。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Chris Buyse | 57 | 2017 | Independent Director |
Sven Francque | - | - | Member of Scientific Advisory Board |
Kenneth Cusi | - | - | Member of Scientific Advisory Board |
Manal Abdelmalek | - | - | Member of Scientific Advisory Board |
Glen Clack | - | - | Member of Scientific Advisory Board |
Jean-Louis Junien | 77 | 2016 | Chairman of Scientific Advisory Board |
Heinz Christoph Maeusli | 58 | 2019 | Independent Director |
Annick Schwebig | 70 | 2017 | Independent Director |
Xiaoqin Lu | 46 | 2018 | Independent Director |
Arun J. Sanyal | - | 2020 | Member of Scientific Advisory Board |
Andrew Shenker | 67 | 2019 | Member of Scientific Advisory Board |
Martine Zimmermann | 53 | 2021 | Independent Director |
Trever Bivona | - | 2022 | Member of the Scientific Advisory Board |
Elisabetta Bugianesi | - | 2022 | Member of the Scientific Advisory Board |
Gérard Zalcman | - | - | Scientific Advisory Board Member |
Frederic Cren | 58 | 2011 | Co-Founder, CEO & Chairman |
Pierre Broqua | 62 | 2011 | Co-Founder, Chief Scientific Officer, Deputy CEO & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核